Sorrento TherapeuticsSRNE
13F holders, Q2 2026 (June 30)5holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were VSM Wealth Advisory, LLC ($66), Huntington National Bank ($4) and Financial Gravity Companies, Inc. ($0).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 569 shares bought, net +569 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| VSM Wealth Advisory, LLC | 0.00% | No change | 110,100 | $66 |
| Huntington National Bank | 0.00% | No change | 5,001 | $4 |
| Financial Gravity Companies, Inc. | 0.00% | — | 18 | $0 |
| Oakworth Capital, Inc. | 0.00% | No change | 350 | $0 |
| First Command Advisory Services, Inc. | 0.00% | New | 569 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.